PetVivo Q3 revenue up 17% YoY to $596K; net loss narrows to $1.75M

PetVivo Holdings, Inc.

2024-Q3 EPS reported -$0.64 revenue$920,440

Revenue $595,891 vs $510,109 YoY; new Covetrus distribution contributed $106K, MWI sales $440K.
Net loss $1,749,848 ($0.12 per share) vs $2,311,618 ($0.23) prior year; gain on extinguishment of payables.
Operating loss $2,133,624 vs $2,318,818; operating expenses flat at $2.55M.
Raised $1.2M in gross proceeds from private offering after quarter end.
Added Diane Levitan, DVM, to board; signed distribution deals with Covetrus and MWV.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

PetVivo Holdings, Inc. reported the three months ended December 31, 2023 results: revenue $595,891, net income ($0.12) per share, EPS ($0.12) per share.

Period: the three months ended December 31, 2023
Revenue: $595,891
Net income: ($0.12) per share
EPS: ($0.12) per share
Result: reported results

Exact text from the filing

Third Quarter Financial Results For The Three Months Ended December 31, 2023 Compared to The Three Months Ended December 31, 2022 Total Revenues . Revenues were $595,891 and $510,109 for three months ended December 31, 2023 and 2022, respectively. Revenues in the three months ended December 31, 2023 consist of sales of our SpryngTM product to MWI

View on SEC.gov

205 earnings releases filed in the last 30 days. Browse all earnings releases →

PetVivo Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-005898

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.